NLS Pharmaceutics (NASDAQ:NLSP) Trading Up 4.3% – Should You Buy?

NLS Pharmaceutics Ltd. (NASDAQ:NLSPGet Free Report)’s share price rose 4.3% on Wednesday . The company traded as high as $1.97 and last traded at $1.96. Approximately 303,553 shares changed hands during trading, a decline of 79% from the average daily volume of 1,478,885 shares. The stock had previously closed at $1.88.

NLS Pharmaceutics Price Performance

The company has a 50-day moving average price of $2.28 and a two-hundred day moving average price of $2.04.

About NLS Pharmaceutics

(Get Free Report)

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).

Recommended Stories

Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.